These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36400028)

  • 1. Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease.
    Ma B; Li T; Li W; Yang H; Zeng Q; Pan Z; Wang K; Chen Q; Xiong C; Zhou Z
    Stem Cell Reports; 2022 Dec; 17(12):2674-2689. PubMed ID: 36400028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease.
    Chen Z; Zhang J; Wei D; Chen J; Yang J
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):677-689. PubMed ID: 33988041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
    Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
    J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
    Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
    Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
    Manaud G; Nossent EJ; Lambert M; Ghigna MR; Boët A; Vinhas MC; Ranchoux B; Dumas SJ; Courboulin A; Girerd B; Soubrier F; Bignard J; Claude O; Lecerf F; Hautefort A; Florio M; Sun B; Nadaud S; Verleden SE; Remy S; Anegon I; Bogaard HJ; Mercier O; Fadel E; Simonneau G; Vonk Noordegraaf A; Grünberg K; Humbert M; Montani D; Dorfmüller P; Antigny F; Perros F
    Am J Respir Cell Mol Biol; 2020 Jul; 63(1):118-131. PubMed ID: 32209028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare compound heterozygous EIF2AK4 mutation in pulmonary veno-occlusive disease.
    Zhang C; Du Q; Wang S; Zhang R
    BMC Pulm Med; 2022 Nov; 22(1):455. PubMed ID: 36451176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival.
    Navas Tejedor P; Palomino Doza J; Tenorio Castaño JA; Enguita Valls AB; Rodríguez Reguero JJ; Martínez Meñaca A; Hernández González I; Bueno Zamora H; Lapunzina Badía PD; Escribano Subías P
    Rev Esp Cardiol (Engl Ed); 2018 Feb; 71(2):86-94. PubMed ID: 28697925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of pulmonary veno-occlusive disease.
    Solinas S; Boucly A; Beurnier A; Kularatne M; Grynblat J; Eyries M; Dorfmüller P; Sitbon O; Humbert M; Montani D
    Expert Rev Respir Med; 2023; 17(8):635-649. PubMed ID: 37578057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.
    Lai YJ; Chen PR; Huang YL; Hsu HH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):300-309. PubMed ID: 31202500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
    Zhang L; Wang Y; Zhang R
    Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid disease progress in a PVOD patient carrying a novel EIF
    Zeng X; Chen F; Rathinasabapathy A; Li T; Adnan Ali Mohammed Mohammed A; Yu Z
    BMC Pulm Med; 2020 Jul; 20(1):186. PubMed ID: 32631303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.
    Katrien M; Dieter S; Anke D; Amelie D; De Pauw M; Eric D
    Acta Clin Belg; 2022 Jun; 77(3):697-702. PubMed ID: 34191691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature.
    Liang L; Ma G; Chen K; Liu Y; Wu X; Ying K; Zhang R
    Medicine (Baltimore); 2016 Sep; 95(39):e5030. PubMed ID: 27684876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].
    Treffel G; Guillaumot A; Gomez E; Eyries M; Petit I; Chabot JF; Chaouat A
    Rev Mal Respir; 2020 Dec; 37(10):823-828. PubMed ID: 33071063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary veno-occlusive disease].
    Boucly A; Girerd B; Bourlier D; Nemlaghi S; Caliez J; Savale L; Jaïs X; Dorfmüller P; Simonneau G; Sitbon O; Humbert M; Montani D
    Rev Mal Respir; 2018 Feb; 35(2):160-170. PubMed ID: 29501213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease.
    Khoury S; Beauvais A; Colas J; Saint-Martin Willer A; Perros F; Humbert M; Vandebrouck C; Montani D; Ferreira T; Antigny F
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary veno-occlusive disease.
    Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
    Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
    Circulation; 2015 Sep; 132(9):834-47. PubMed ID: 26130118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.
    Montani D; Lau EM; Descatha A; Jaïs X; Savale L; Andujar P; Bensefa-Colas L; Girerd B; Zendah I; Le Pavec J; Seferian A; Perros F; Dorfmüller P; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2015 Dec; 46(6):1721-31. PubMed ID: 26541523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.